| Jason Vergnani, MD | |
|
801 S Stevens St, Spokane, WA 99204-2654 | |
| (509) 363-7788 | |
| Not Available |
| Full Name | Jason Vergnani |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 801 S Stevens St, Spokane, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053604090 | NPI | - | NPPES |
| 2049531 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | MD6048104 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prov Sacred Hrt Med Ctr & Childs Hosp. | Spokane, WA | Hospital |
| Kadlec Regional Medical Center | Richland, WA | Hospital |
| Providence Holy Family Hospital | Spokane, WA | Hospital |
| Providence Mount Carmel Hospital | Colville, WA | Hospital |
| Providence St Mary Medical Center | Walla walla, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Moses Lake Community Health Center | 1254235138 | 55 |
| Integra Imaging Ps | 1355593062 | 119 |
| The Polyclinic | 2163328196 | 346 |
| Inland Imaging Llc | 6608763016 | 121 |
| Inland Imaging Associates Ps | 7810327210 | 117 |
| Integra Imaging Ps | 1355593062 | 119 |
| Inland Imaging Associates Ps | 7810327210 | 117 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Moses Lake Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699862813 PECOS PAC ID: 1254235138 Enrollment ID: O20031121000667 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | The Polyclinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174594634 PECOS PAC ID: 2163328196 Enrollment ID: O20031210000788 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Grant County Hospital District No. 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659445468 PECOS PAC ID: 8921919077 Enrollment ID: O20040116000955 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Okanogan Douglas County Hospital Dist 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205942257 PECOS PAC ID: 7810882792 Enrollment ID: O20040219000122 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Inland Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851352348 PECOS PAC ID: 6608763016 Enrollment ID: O20040301001171 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Columbia County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134128911 PECOS PAC ID: 5597653758 Enrollment ID: O20040309000515 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Okanogan Douglas County Hospital Dist 1 |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1356305395 PECOS PAC ID: 7810882792 Enrollment ID: O20080107000645 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Integra Imaging Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205189461 PECOS PAC ID: 1355593062 Enrollment ID: O20121204000044 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Entity Name | Inland Imaging Associates Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982236469 PECOS PAC ID: 7810327210 Enrollment ID: O20200427002479 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Vergnani, MD 801 S Stevens St, Spokane, WA 99204-2654 Ph: (509) 363-7788 | Jason Vergnani, MD 801 S Stevens St, Spokane, WA 99204-2654 Ph: (509) 363-7788 |
News Archive
A new scientific study conducted by a team of leading geneticists has characterized how cells know when to stop translating DNA into proteins, a critical step in maintaining healthy protein levels and cell function.
A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
› Verified 4 days ago
Thomas E Richardson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 400 E 5th Ave, Spokane, WA 99202 Phone: 509-838-2531 | |
Jodi L Bailey, MD Radiology Medicare: Medicare Enrolled Practice Location: 801 S Stevens St, Spokane, WA 99204 Phone: 509-747-4455 Fax: 509-363-7064 | |
William E Schulte, MD Radiology Medicare: Medicare Enrolled Practice Location: 801 S Stevens St, Spokane, WA 99204 Phone: 509-747-4455 Fax: 509-363-7064 | |
Brad J Ratcliff, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1314 E Susan Ln, Spokane, WA 99223 Phone: 509-953-0145 | |
Dr. Richard Frankland Kennard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 S Stevens St, Spokane, WA 99204 Phone: 509-363-7788 | |
Dr. Gurpreet Singh Dhillon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 801 S Stevens St, Spokane, WA 99204 Phone: 509-747-4455 Fax: 509-363-7064 |